The Role of EUS-BD in the Management of Malignant Biliary Obstruction: The Indonesian Perspective

Table 3

Patient characteristics and bilirubin levels before and after the procedure.

Patient	Gender	Age (years)	BMI	Primary disease	Total/direct bilirubin (TB/DB) before procedure (mg/dL)	Total/direct bilirubin (TB/DB) one week after the procedure (mg/dL)
(1)	Male	73	27.3	Periampullary tumor	25.75/22.4	8.71/7
(2)	Male	43	17.3	Tumor of head of pancreas	24.46/20.27	18.72/15.53
(3)	Female	58	21.4	Tumor of head of pancreas	37.85/29.85	13.22/11.71
(4)	Female	66	10.5	Periampullary tumor	16.02/13.99	10.86/9.42
(5)	Male	75	28.51	Tumor of head of pancreas	30.02/24.45	14.75/12.87
(6)	Male	77	25.71	Tumor of head of pancreas	18.25/15.65	14.41/10.89
(7)	Male	54	18.37	Tumor of head of pancreas	3.89/2.8	1.41/1.09
(8)	Female	63	15.62	Periampullary tumor	23.87/20.23	15.83/14,46
(9)	Female	63	18.73	Tumor of head of pancreas	9.9/9.3	13.9/12.79
(10)	Male	41	19.5	Tumor of head of pancreas	20.6/18.8	15.06/13.52
(11)	Female	76	17.5	Tumor of head of pancreas	15.28/14.53	13.75/12.33
(12)	Female	43	18.7	Periampullary tumor	13.88/12.90	4.45/3.98
(13)	Female	59	19	Periampullary tumor	14.21/12.48	10.11/8.35
(14)	Female	78	21.22	Periampullary tumor	21/18	4.67/3.23
(15)	Female	64	25.7	Periampullary tumor	9.15/8.06	6.4/5.3
(16)	Male	54	19.92	Tumor of head of pancreas	18.4/17.06	9.11/5.8
(17)	Male	37	17.3	Periampullary tumor	8.7/6.6	6.03/4.79
(18)	Male	58	19.53	Periampullary tumor	29.4/21.75	21.53/19.08
(19)	Male	63	21.30	Periampullary tumor	22.06/19.91	3.6/3.5
(20)	Male	53	25.34	Tumor of head of pancreas	25.64/23.08	20.22/17.42
(21)	Male	46	17.93	Tumor of head of pancreas	29.32/22.75	6.63/5.58
(22)	Female	80	18.73	Cholangiocarcinoma	29.13/25.83	16.74/15.34
(23)	Female	45	26.03	Tumor of head of pancreas	28.26/25.4	14.08/12.1
(24)	Male	52	17.5	Tumor of head of pancreas	13.69/11.02	11.36/9.52